RMD 1.05% $37.39 resmed inc

From MF: The lower-than-anticipated quarterly results were the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 249 Posts.
    From MF:

    The lower-than-anticipated quarterly results were the result of a worrying sales decline in its key North American markets. Recently selling for $5.50 (US$51.50) the market has been pricing ResMed as a growth stock selling on more than 21 times diluted earnings per shares of $US2.39 for financial year 2014. This growth stock status is likely to come under pressure as the weak North American numbers suggest changes to U.S. Medicare spending and reimbursement patterns have taken their toll.

    (One para only - see MF site for more)

    I got out a few weeks ago (wisely or unwisely) on the back of a warning from one analyst about changing US regs around Medicare which might affect RMD. Now hoping for a reentry further down the price scale, as punters assess/reassess the scale of the "growth" narrative on which SP has been rising.

    Thoughts?
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$37.39
Change
0.390(1.05%)
Mkt cap ! $22.38B
Open High Low Value Volume
$37.30 $37.39 $37.07 $9.449M 253.3K

Buyers (Bids)

No. Vol. Price($)
1 44 $37.32
 

Sellers (Offers)

Price($) Vol. No.
$37.39 2573 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
RMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.